Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1995 May;100(2):186–193. doi: 10.1111/j.1365-2249.1995.tb03651.x

Cell-mediated autoimmunity in patients with Wegener's granulomatosis (WG)

B E Ballieux 1, S H van der Burg 1, E C Hagen 1, F J van der Woude 1, C J Melief 1, M R Daha 1
PMCID: PMC1534319  PMID: 7743653

Abstract

Despite the well described infiltration of cells of the cellular immune system in vasculitic lesions and the granuloma formation in patients with WG, the role of T cell-mediated autoimmunity in WG is not clear. Reports of T cell proliferation in response to neutrophil azurophilic granule proteins are contradictory. In this study we have assessed the proliferation of T cells of WG patients to purified proteinase 3 (PR3) and to total azurophilic granule proteins in two different assays. In addition to the classical proliferation assay with isolated peripheral blood mononuclear cells, we have used a whole blood proliferation assay. In both assays we found proliferative responses to PR3 in patients with WG. The number of patients reacting to the azurophilic granule extract was higher than the patients reacting to the purified PR3, suggesting that other autoantigens may also be involved. We have identified epitopes of PR3 that may be potential targets of class I-restricted T cell responses in the context of HLA-A*0201, the most common MHC class I molecule. These epitopes were determined by the binding of synthetic PR3 peptides to HLA-A*0201 on the antigen-processing defective cell line, T2. In addition, T cell lines were established from tissue biopsies, obtained from WG patients, and assessed for cytolytic reactivity against T2 cells, preloaded with synthetic PR3 peptides. We conclude that T lymphocytes of WG patients have increased proliferative responses to purified PR3 and to a larger extent to non-fractionated proteins of azurophilic granules of polymorphonuclear neutrophilic leucocytes (PMN).

Full text

PDF
186

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berrih-Aknin S., Cohen-Kaminsky S., Lepage V., Neumann D., Bach J. F., Fuchs S. T-cell antigenic sites involved in myasthenia gravis: correlations with antibody titre and disease severity. J Autoimmun. 1991 Feb;4(1):137–153. doi: 10.1016/0896-8411(91)90013-3. [DOI] [PubMed] [Google Scholar]
  2. Bloemena E., Roos M. T., Van Heijst J. L., Vossen J. M., Schellekens P. T. Whole-blood lymphocyte cultures. J Immunol Methods. 1989 Sep 1;122(2):161–167. doi: 10.1016/0022-1759(89)90260-3. [DOI] [PubMed] [Google Scholar]
  3. Bolton W. K., Innes D. J., Jr, Sturgill B. C., Kaiser D. L. T-cells and macrophages in rapidly progressive glomerulonephritis: clinicopathologic correlations. Kidney Int. 1987 Dec;32(6):869–876. doi: 10.1038/ki.1987.288. [DOI] [PubMed] [Google Scholar]
  4. Borregaard N., Heiple J. M., Simons E. R., Clark R. A. Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation. J Cell Biol. 1983 Jul;97(1):52–61. doi: 10.1083/jcb.97.1.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brouwer E., Tervaert J. W., Horst G., Huitema M. G., van der Giessen M., Limburg P. C., Kallenberg C. G. Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders. Clin Exp Immunol. 1991 Mar;83(3):379–386. doi: 10.1111/j.1365-2249.1991.tb05647.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Champion B. R., Page K. R., Parish N., Rayner D. C., Dawe K., Biswas-Hughes G., Cooke A., Geysen M., Roitt I. M. Identification of a thyroxine-containing self-epitope of thyroglobulin which triggers thyroid autoreactive T cells. J Exp Med. 1991 Aug 1;174(2):363–370. doi: 10.1084/jem.174.2.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Charles L. A., Caldas M. L., Falk R. J., Terrell R. S., Jennette J. C. Antibodies against granule proteins activate neutrophils in vitro. J Leukoc Biol. 1991 Dec;50(6):539–546. doi: 10.1002/jlb.50.6.539. [DOI] [PubMed] [Google Scholar]
  8. Churg J. Nomenclature of vasculitic syndromes: a historical perspective. Am J Kidney Dis. 1991 Aug;18(2):148–153. doi: 10.1016/s0272-6386(12)80871-7. [DOI] [PubMed] [Google Scholar]
  9. Clerici M., Lucey D. R., Berzofsky J. A., Pinto L. A., Wynn T. A., Blatt S. P., Dolan M. J., Hendrix C. W., Wolf S. F., Shearer G. M. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science. 1993 Dec 10;262(5140):1721–1724. doi: 10.1126/science.7903123. [DOI] [PubMed] [Google Scholar]
  10. Ewert B. H., Jennette J. C., Falk R. J. Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kidney Int. 1992 Feb;41(2):375–383. doi: 10.1038/ki.1992.52. [DOI] [PubMed] [Google Scholar]
  11. Ewins D. L., Barnett P. S., Ratanachaiyavong S., Sharrock C., Lanchbury J., McGregor A. M., Banga J. P. Antigen-specific T cell recognition of affinity-purified and recombinant thyroid peroxidase in autoimmune thyroid disease. Clin Exp Immunol. 1992 Oct;90(1):93–98. doi: 10.1111/j.1365-2249.1992.tb05838.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Falk K., Rötzschke O., Stevanović S., Jung G., Rammensee H. G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature. 1991 May 23;351(6324):290–296. doi: 10.1038/351290a0. [DOI] [PubMed] [Google Scholar]
  13. Feltkamp M. C., Smits H. L., Vierboom M. P., Minnaar R. P., de Jongh B. M., Drijfhout J. W., ter Schegget J., Melief C. J., Kast W. M. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur J Immunol. 1993 Sep;23(9):2242–2249. doi: 10.1002/eji.1830230929. [DOI] [PubMed] [Google Scholar]
  14. Franco A., Barnaba V., Ruberti G., Benvenuto R., Balsano C., Musca A. Liver-derived T cell clones in autoimmune chronic active hepatitis: accessory cell function of hepatocytes expressing class II major histocompatibility complex molecules. Clin Immunol Immunopathol. 1990 Mar;54(3):382–394. doi: 10.1016/0090-1229(90)90052-r. [DOI] [PubMed] [Google Scholar]
  15. GODMAN G. C., CHURG J. Wegener's granulomatosis: pathology and review of the literature. AMA Arch Pathol. 1954 Dec;58(6):533–553. [PubMed] [Google Scholar]
  16. Gephardt G. N., Ahmad M., Tubbs R. R. Pulmonary vasculitis (Wegener's granulomatosis). Immunohistochemical study of T and B cell markers. Am J Med. 1983 Apr;74(4):700–704. doi: 10.1016/0002-9343(83)91030-6. [DOI] [PubMed] [Google Scholar]
  17. Goldschmeding R., van der Schoot C. E., ten Bokkel Huinink D., Hack C. E., van den Ende M. E., Kallenberg C. G., von dem Borne A. E. Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest. 1989 Nov;84(5):1577–1587. doi: 10.1172/JCI114335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hagen E. C., Ballieux B. E., van Es L. A., Daha M. R., van der Woude F. J. Antineutrophil cytoplasmic autoantibodies: a review of the antigens involved, the assays, and the clinical and possible pathogenetic consequences. Blood. 1993 Apr 15;81(8):1996–2002. [PubMed] [Google Scholar]
  19. Hashimoto E., Lindor K. D., Homburger H. A., Dickson E. R., Czaja A. J., Wiesner R. H., Ludwig J. Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. Mayo Clin Proc. 1993 Nov;68(11):1049–1055. doi: 10.1016/s0025-6196(12)60897-0. [DOI] [PubMed] [Google Scholar]
  20. Itoh N., Hanafusa T., Miyazaki A., Miyagawa J., Yamagata K., Yamamoto K., Waguri M., Imagawa A., Tamura S., Inada M. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J Clin Invest. 1993 Nov;92(5):2313–2322. doi: 10.1172/JCI116835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kast W. M., Brandt R. M., Drijfhout J. W., Melief C. J. Human leukocyte antigen-A2.1 restricted candidate cytotoxic T lymphocyte epitopes of human papillomavirus type 16 E6 and E7 proteins identified by using the processing-defective human cell line T2. J Immunother Emphasis Tumor Immunol. 1993 Aug;14(2):115–120. doi: 10.1097/00002371-199308000-00006. [DOI] [PubMed] [Google Scholar]
  22. Katz P., Alling D. W., Haynes B. F., Fauci A. S. Association of Wegener's granulomatosis with HLA-B8. Clin Immunol Immunopathol. 1979 Oct;14(2):268–270. doi: 10.1016/0090-1229(79)90150-8. [DOI] [PubMed] [Google Scholar]
  23. Keogan M. T., Esnault V. L., Green A. J., Lockwood C. M., Brown D. L. Activation of normal neutrophils by anti-neutrophil cytoplasm antibodies. Clin Exp Immunol. 1992 Nov;90(2):228–234. doi: 10.1111/j.1365-2249.1992.tb07934.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Leid R. W., Ballieux B. E., van der Heijden I., Kleyburg-van der Keur C., Hagen E. C., van Es L. A., van der Woude F. J., Daha M. R. Cleavage and inactivation of human C1 inhibitor by the human leukocyte proteinase, proteinase 3. Eur J Immunol. 1993 Nov;23(11):2939–2944. doi: 10.1002/eji.1830231132. [DOI] [PubMed] [Google Scholar]
  25. Lüdemann J., Utecht B., Gross W. L. Detection and quantitation of anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis by ELISA using affinity-purified antigen. J Immunol Methods. 1988 Nov 10;114(1-2):167–174. doi: 10.1016/0022-1759(88)90169-x. [DOI] [PubMed] [Google Scholar]
  26. Malnati M. S., Marti M., LaVaute T., Jaraquemada D., Biddison W., DeMars R., Long E. O. Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells. Nature. 1992 Jun 25;357(6380):702–704. doi: 10.1038/357702a0. [DOI] [PubMed] [Google Scholar]
  27. Mathieson P. W., Lockwood C. M., Oliveira D. B. T and B cell responses to neutrophil cytoplasmic antigens in systemic vasculitis. Clin Immunol Immunopathol. 1992 May;63(2):135–141. doi: 10.1016/0090-1229(92)90005-9. [DOI] [PubMed] [Google Scholar]
  28. Mayet W. J., Csernok E., Szymkowiak C., Gross W. L., Meyer zum Büschenfelde K. H. Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosis. Blood. 1993 Aug 15;82(4):1221–1229. [PubMed] [Google Scholar]
  29. Mayet W. J., Hermann E. M., Csernok E., Gross W. L., Meyer zum Büschenfelde K. H. In vitro interactions of c-ANCA (antibodies to proteinase 3) with human endothelial cells. Adv Exp Med Biol. 1993;336:109–113. doi: 10.1007/978-1-4757-9182-2_18. [DOI] [PubMed] [Google Scholar]
  30. Mohan C., Adams S., Stanik V., Datta S. K. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med. 1993 May 1;177(5):1367–1381. doi: 10.1084/jem.177.5.1367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Moodie F. D., Leaker B., Cambridge G., Totty N. F., Segal A. W. Alpha-enolase: a novel cytosolic autoantigen in ANCA positive vasculitis. Kidney Int. 1993 Mar;43(3):675–681. doi: 10.1038/ki.1993.97. [DOI] [PubMed] [Google Scholar]
  32. Mulder A. H., Heeringa P., Brouwer E., Limburg P. C., Kallenberg C. G. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a Fc gamma RII-dependent process. Clin Exp Immunol. 1994 Nov;98(2):270–278. doi: 10.1111/j.1365-2249.1994.tb06137.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Murty G. E., Mains B. T., Middleton D., Maxwell A. P., Savage D. A. HLA antigen frequencies and Wegener's granulomatosis. Clin Otolaryngol Allied Sci. 1991 Oct;16(5):448–451. doi: 10.1111/j.1365-2273.1991.tb01037.x. [DOI] [PubMed] [Google Scholar]
  34. Nijman H. W., Houbiers J. G., Vierboom M. P., van der Burg S. H., Drijfhout J. W., D'Amaro J., Kenemans P., Melief C. J., Kast W. M. Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes. Eur J Immunol. 1993 Jun;23(6):1215–1219. doi: 10.1002/eji.1830230603. [DOI] [PubMed] [Google Scholar]
  35. Nijman H. W., Van der Burg S. H., Vierboom M. P., Houbiers J. G., Kast W. M., Melief C. J. p53, a potential target for tumor-directed T cells. Immunol Lett. 1994 May;40(2):171–178. doi: 10.1016/0165-2478(94)90189-9. [DOI] [PubMed] [Google Scholar]
  36. Onishi S., Saibara T., Nakata S., Maeda T., Iwasaki S., Iwamura S., Miyazaki M., Yamamoto Y., Enzan H. Cytotoxic activity of spleen-derived T lymphocytes against autologous biliary epithelial cells in autopsy patients with primary biliary cirrhosis. Liver. 1993 Aug;13(4):188–192. doi: 10.1111/j.1600-0676.1993.tb00629.x. [DOI] [PubMed] [Google Scholar]
  37. Papiha S. S., Murty G. E., Ad'Hia A., Mains B. T., Venning M. Association of Wegener's granulomatosis with HLA antigens and other genetic markers. Ann Rheum Dis. 1992 Feb;51(2):246–248. doi: 10.1136/ard.51.2.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Rammensee H. G., Falk K., Rötzschke O. Peptides naturally presented by MHC class I molecules. Annu Rev Immunol. 1993;11:213–244. doi: 10.1146/annurev.iy.11.040193.001241. [DOI] [PubMed] [Google Scholar]
  39. Rasmussen N., Petersen J. Cellular immune responses and pathogenesis in c-ANCA positive vasculitides. J Autoimmun. 1993 Apr;6(2):227–236. doi: 10.1006/jaut.1993.1020. [DOI] [PubMed] [Google Scholar]
  40. Res P. C., Schaar C. G., Breedveld F. C., van Eden W., van Embden J. D., Cohen I. R., de Vries R. R. Synovial fluid T cell reactivity against 65 kD heat shock protein of mycobacteria in early chronic arthritis. Lancet. 1988 Aug 27;2(8609):478–480. doi: 10.1016/s0140-6736(88)90123-7. [DOI] [PubMed] [Google Scholar]
  41. Roep B. O., Kallan A. A., De Vries R. R. Beta-cell antigen-specific lysis of macrophages by CD4 T-cell clones from newly diagnosed IDDM patient. A putative mechanism of T-cell-mediated autoimmune islet cell destruction. Diabetes. 1992 Nov;41(11):1380–1384. doi: 10.2337/diab.41.11.1380. [DOI] [PubMed] [Google Scholar]
  42. Roep B. O., Kallan A. A., Hazenbos W. L., Bruining G. J., Bailyes E. M., Arden S. D., Hutton J. C., de Vries R. R. T-cell reactivity to 38 kD insulin-secretory-granule protein in patients with recent-onset type 1 diabetes. Lancet. 1991 Jun 15;337(8755):1439–1441. doi: 10.1016/0140-6736(91)93127-u. [DOI] [PubMed] [Google Scholar]
  43. Savage C. O., Pottinger B. E., Gaskin G., Pusey C. D., Pearson J. D. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. Am J Pathol. 1992 Aug;141(2):335–342. [PMC free article] [PubMed] [Google Scholar]
  44. Spiegelberg H. L. Biological role of different antibody classes. Int Arch Allergy Appl Immunol. 1989;90 (Suppl 1):22–27. doi: 10.1159/000235071. [DOI] [PubMed] [Google Scholar]
  45. St Louis J. D., Lederer J. A., Lichtman A. H. Costimulator deficient antigen presentation by an endothelial cell line induces a nonproliferative T cell activation response without anergy. J Exp Med. 1993 Nov 1;178(5):1597–1605. doi: 10.1084/jem.178.5.1597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Stegeman C. A., Tervaert J. W., Huitema M. G., Kallenberg C. G. Serum markers of T cell activation in relapses of Wegener's granulomatosis. Clin Exp Immunol. 1993 Mar;91(3):415–420. doi: 10.1111/j.1365-2249.1993.tb05918.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Wei M. L., Cresswell P. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature. 1992 Apr 2;356(6368):443–446. doi: 10.1038/356443a0. [DOI] [PubMed] [Google Scholar]
  48. van de Wiel B. A., Dolman K. M., van der Meer-Gerritsen C. H., Hack C. E., von dem Borne A. E., Goldschmeding R. Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity. Clin Exp Immunol. 1992 Dec;90(3):409–414. doi: 10.1111/j.1365-2249.1992.tb05860.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES